Robert W. Baird Cuts Cognex (NASDAQ:CGNX) Price Target to $70.00

Key Points

• Robert W. Baird lowered Cognex’s price target from $78 to $70 while maintaining a “neutral” rating, implying 18.7% potential upside from the previous close.
• Cognex reported quarterly EPS of $0.45, exceeding the $0.42 consensus estimate, while revenue rose 16.9% year over year to $291.26 million, slightly below expectations.
• Analyst sentiment remains moderately positive, with a consensus “Moderate Buy” rating and $75.50 target; however, investors are weighing the growth potential of the RealSense acquisition against its $500 million cost and integration risks.

Cognex (NASDAQ:CGNX - Get Free Report) had its target price cut by Robert W. Baird from $78.00 to $70.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has a "neutral" rating on the scientific and technical instruments company's stock. Robert W. Baird's price target points to a potential upside of 18.70% from the company's previous close.

Other analysts also recently issued reports about the company. DA Davidson set a $65.00 price objective on Cognex and gave the stock a "neutral" rating in a research report on Monday, August 10th. Truist Financial upped their target price on shares of Cognex from $71.00 to $78.00 and gave the company a "hold" rating in a research report on Friday, August 7th. Seaport Research Partners set a $75.00 target price on shares of Cognex in a research note on Tuesday, May 26th. JPMorgan Chase & Co. upgraded shares of Cognex from a "neutral" rating to an "overweight" rating and lifted their price target for the company from $65.00 to $75.00 in a research report on Tuesday, May 26th. Finally, The Goldman Sachs Group restated a "buy" rating and issued a $91.00 price objective on shares of Cognex in a report on Friday, August 7th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $75.50.

Cognex Price Performance

NASDAQ CGNX opened at $58.97 on Wednesday. The company has a market cap of $9.92 billion, a PE ratio of 57.25 and a beta of 1.49. The stock's 50 day simple moving average is $62.50 and its 200-day simple moving average is $60.33. Cognex has a 1-year low of $34.60 and a 1-year high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.03. The firm had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. Cognex's quarterly revenue was up 16.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.25 earnings per share. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, equities research analysts anticipate that Cognex will post 1.68 EPS for the current fiscal year.

Hedge Funds Weigh In On Cognex

Several hedge funds have recently added to or reduced their stakes in the stock. IFP Advisors Inc lifted its position in Cognex by 21.6% during the 2nd quarter. IFP Advisors Inc now owns 956 shares of the scientific and technical instruments company's stock worth $69,000 after buying an additional 170 shares in the last quarter. State of Michigan Retirement System increased its position in shares of Cognex by 0.5% in the first quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company's stock valued at $1,952,000 after acquiring an additional 200 shares during the last quarter. Personal CFO Solutions LLC raised its holdings in Cognex by 3.2% during the first quarter. Personal CFO Solutions LLC now owns 6,793 shares of the scientific and technical instruments company's stock worth $333,000 after acquiring an additional 212 shares in the last quarter. World Investment Advisors raised its holdings in Cognex by 3.7% during the first quarter. World Investment Advisors now owns 6,073 shares of the scientific and technical instruments company's stock worth $298,000 after acquiring an additional 214 shares in the last quarter. Finally, Essential Partners LLC boosted its position in Cognex by 12.5% during the first quarter. Essential Partners LLC now owns 2,153 shares of the scientific and technical instruments company's stock valued at $105,000 after purchasing an additional 239 shares during the last quarter. 88.12% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: The acquisition adds RealSense’s 3D perception platform and is expected to expand Cognex’s addressable market, particularly in robotics applications requiring cameras and vision systems to identify, locate, and manipulate objects. Management characterized the transaction as supporting growth diversification. Cognex to Acquire RealSense, Expanding Machine Vision Leadership into High-Growth Robotic Perception Market
• Positive Sentiment: Needham initiated Cognex at Buy with an $80 price target, citing the RealSense transaction and an expanding robotic-perception opportunity. That target is meaningfully above the company’s recent trading range and signals potential upside if the acquisition accelerates growth. Cognex Initiated at Buy on RealSense Acquisition
• Neutral Sentiment: D.A. Davidson kept a Hold rating and its $65 target, viewing the deal valuation as broadly fair rather than immediately accretive. The split analyst reaction suggests investors are weighing RealSense’s strategic potential against the purchase price and the time needed to realize synergies. Cognex Maintained at Hold as RealSense Deal Seen Fairly Valued
• Negative Sentiment: The $500 million cash outlay creates execution, integration, and return-on-investment risks, while Cognex already trades at a relatively high valuation of roughly 57 times earnings. Investors may therefore demand evidence that RealSense can contribute meaningfully to revenue and earnings growth. Cognex To Buy RealSense For $500 Million

Cognex Company Profile

Cognex Corporation NASDAQ: CGNX develops machine vision technologies that help businesses automate inspection, identification, measurement and guidance tasks. Its systems enable manufacturing and logistics operations to analyze images and make decisions about products, components and packages.

The company's product portfolio includes industrial cameras, vision sensors, barcode readers, three-dimensional vision systems and machine vision software. Cognex also offers artificial intelligence and deep-learning tools designed to address complex inspection and classification applications, along with engineering, implementation and support services.

Founded in 1981 by Robert J.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.